Novartis Investigative Site

Huy / OT Anderbeck 38836

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Chronic Heart Failure With Reduced Ejection Fraction, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed